Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Methotrexate is the leading DMARD in Finland

Identifieur interne : 002089 ( Main/Exploration ); précédent : 002088; suivant : 002090

Methotrexate is the leading DMARD in Finland

Auteurs : T. Klaukka [Finlande] ; K. Kaarela [Finlande]

Source :

RBID : ISTEX:688B87F265411E3B5DD728128E8F6C9859358490

English descriptors


Url:
DOI: 10.1136/ard.62.5.494


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Methotrexate is the leading DMARD in Finland</title>
<author>
<name sortKey="Klaukka, T" sort="Klaukka, T" uniqKey="Klaukka T" first="T" last="Klaukka">T. Klaukka</name>
</author>
<author>
<name sortKey="Kaarela, K" sort="Kaarela, K" uniqKey="Kaarela K" first="K" last="Kaarela">K. Kaarela</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:688B87F265411E3B5DD728128E8F6C9859358490</idno>
<date when="2003" year="2003">2003</date>
<idno type="doi">10.1136/ard.62.5.494</idno>
<idno type="url">https://api.istex.fr/ark:/67375/NVC-GRG1T84C-K/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000562</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000562</idno>
<idno type="wicri:Area/Istex/Curation">000562</idno>
<idno type="wicri:Area/Istex/Checkpoint">000F24</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000F24</idno>
<idno type="wicri:doubleKey">0003-4967:2003:Klaukka T:methotrexate:is:the</idno>
<idno type="wicri:Area/Main/Merge">002107</idno>
<idno type="wicri:Area/Main/Curation">002089</idno>
<idno type="wicri:Area/Main/Exploration">002089</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Methotrexate is the leading DMARD in Finland</title>
<author>
<name sortKey="Klaukka, T" sort="Klaukka, T" uniqKey="Klaukka T" first="T" last="Klaukka">T. Klaukka</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Finlande</country>
<wicri:regionArea>Social Insurance Institution, Helsinki</wicri:regionArea>
<wicri:noRegion>Helsinki</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kaarela, K" sort="Kaarela, K" uniqKey="Kaarela K" first="K" last="Kaarela">K. Kaarela</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Finlande</country>
<wicri:regionArea>Rheumatism Foundation Hospital, Heinola</wicri:regionArea>
<wicri:noRegion>Heinola</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Annals of the Rheumatic Diseases</title>
<title level="j" type="abbrev">Ann Rheum Dis</title>
<idno type="ISSN">0003-4967</idno>
<idno type="eISSN">1468-2060</idno>
<imprint>
<publisher>BMJ Publishing Group Ltd and European League Against Rheumatism</publisher>
<date type="published" when="2003-05">2003-05</date>
<biblScope unit="volume">62</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="494">494</biblScope>
</imprint>
<idno type="ISSN">0003-4967</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0003-4967</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>disease modifying antirheumatic drugs</term>
<term>methotrexate</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en">
<term>Annual meeting</term>
<term>Antirheumatic drugs</term>
<term>Arthritis</term>
<term>Assoc physicians india</term>
<term>Clinical usage</term>
<term>Combination therapies</term>
<term>Corticosteroid</term>
<term>Corticosteroid treatment</term>
<term>Dmards</term>
<term>Early diagnosis</term>
<term>Email</term>
<term>Eular</term>
<term>Finland</term>
<term>Glucocorticoid</term>
<term>Glucocorticoid therapy</term>
<term>Isoniazid prophylaxis</term>
<term>Methotrexate</term>
<term>Organising secretariat</term>
<term>Osteoarthritis</term>
<term>Practical progress</term>
<term>Rapid rise</term>
<term>Rheum</term>
<term>Rheumatic diseases</term>
<term>Rheumatoid arthritis</term>
<term>Rheumatology</term>
<term>Sarcoidosis</term>
<term>Systemic lupus erythematosus</term>
<term>Website</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<affiliations>
<list>
<country>
<li>Finlande</li>
</country>
</list>
<tree>
<country name="Finlande">
<noRegion>
<name sortKey="Klaukka, T" sort="Klaukka, T" uniqKey="Klaukka T" first="T" last="Klaukka">T. Klaukka</name>
</noRegion>
<name sortKey="Kaarela, K" sort="Kaarela, K" uniqKey="Kaarela K" first="K" last="Kaarela">K. Kaarela</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002089 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002089 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:688B87F265411E3B5DD728128E8F6C9859358490
   |texte=   Methotrexate is the leading DMARD in Finland
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021